Supplemental Methods and Figure S1 from SIRT6 Promotes COX-2 Expression and Acts as an Oncogene in Skin Cancer

Mei Ming,Weinong Han,Baozhong Zhao,Nagalingam R. Sundaresan,Chu-Xia Deng,Mahesh P. Gupta,Yu-Ying He

DOI: https://doi.org/10.1158/0008-5472.22404237

2023-01-01

Abstract:Supplemental Methods and Supplemental Figure S1: SIRT6 has no effect on UVB-induced DNA damage repair and checkpoint activation

What problem does this paper attempt to address?

Data from SIRT6 Promotes COX-2 Expression and Acts as an Oncogene in Skin Cancer

Mei Ming,Weinong Han,Baozhong Zhao,Nagalingam R. Sundaresan,Chu-Xia Deng,Mahesh P. Gupta,Yu-Ying He

DOI: https://doi.org/10.1158/0008-5472.c.6506559

2023-01-01

Abstract:AbstractSIRT6 is a SIR2 family member that regulates multiple molecular pathways involved in metabolism, genomic stability, and aging. It has been proposed previously that SIRT6 is a tumor suppressor in cancer. Here, we challenge this concept by presenting evidence that skin-specific deletion of SIRT6 in the mouse inhibits skin tumorigenesis. SIRT6 promoted expression of COX-2 by repressing AMPK signaling, thereby increasing cell proliferation and survival in the skin epidermis. SIRT6 expression in skin keratinocytes was increased by exposure to UVB light through activation of the AKT pathway. Clinically, we found that SIRT6 was upregulated in human skin squamous cell carcinoma. Taken together, our results provide evidence that SIRT6 functions as an oncogene in the epidermis and suggest greater complexity to its role in epithelial carcinogenesis. Cancer Res; 74(20); 5925–33. ©2014 AACR.
Tumor and Stem Cell Biology SIRT 6 Promotes COX-2 Expression and Acts as an Oncogene in Skin Cancer

Mei Ming,Weinong Han,Baozhong Zhao,Nagalingam R. Sundaresan,Chu-Xia Deng,Mahesh P. Gupta,Yu-Ying He

2014-01-01

Abstract:SIRT6 is a SIR2 family member that regulates multiple molecular pathways involved in metabolism, genomic stability, and aging. It has been proposedpreviously that SIRT6 is a tumor suppressor in cancer. Here, we challenge this concept by presenting evidence that skin-specific deletion of SIRT6 in themouse inhibits skin tumorigenesis. SIRT6 promoted expression of COX-2 by repressing AMPK signaling, thereby increasing cell proliferation and survival in the skin epidermis. SIRT6 expression in skin keratinocytes was increased by exposure to UVB light through activation of the AKT pathway. Clinically, we found that SIRT6was upregulated in human skin squamous cell carcinoma. Taken together, our results provide evidence that SIRT6 functions as an oncogene in the epidermis and suggest greater complexity to its role in epithelial carcinogenesis. Cancer Res; 74(20); 5925–33. 2014 AACR.
Supplemental Figures 1-5 from SIRT2 Deacetylates and Inhibits the Peroxidase Activity of Peroxiredoxin-1 to Sensitize Breast Cancer Cells to Oxidant Stress-Inducing Agents

Warren Fiskus,Veena Coothankandaswamy,Jianguang Chen,Hongwei Ma,Kyungsoo Ha,Dyana T. Saenz,Stephanie S. Krieger,Christopher P. Mill,Baohua Sun,Peng Huang,Jeffrey S. Mumm,Ari M. Melnick,Kapil N. Bhalla

DOI: https://doi.org/10.1158/0008-5472.22413911

2023-01-01

Abstract:Supplemental Figure 1. Relative activity of overexpressed SIRT2 in breast cancer cells Supplemental Figure 2. Expression of other sirtuin proteins and HDAC6 in SIRT2 O/E and knockdown cells Supplemental Figure 3. SIRT2 overexpression increases Prdx1 chaperone activity in HEK293 cells treated with H2O2. Supplemental Figure 4. Effects of SIRT2 overexpression on FOXO3A localization Supplemental Figure 5. Schematic of the zebrafish SIRT2 gene and splice-blocking exon 6 morpholino.
Supplementary Figure 3 from Overexpression of Sirt7 Exhibits Oncogenic Property and Serves as a Prognostic Factor in Colorectal Cancer

Hongyan Yu,Wen Ye,Jiangxue Wu,Xiangqi Meng,Ran-yi Liu,Xiaofang Ying,Yi Zhou,Hui Wang,Changchuan Pan,Wenlin Huang

DOI: https://doi.org/10.1158/1078-0432.22449446.v1

2023-01-01

Abstract:PDF file - 2323KB, Effect of Sirt7 on CRC cell growth and metastasis in vivo. (A) Mice were injected subcutaneously with cells (105 cells/mouse). Tumor weight were measured after mice were euthanised, plotted as the mean� SEM. The left panel displays tumor growth in nude mice injected with the two groups of cells (Sirt7-HT29 and ctrl-HT29). (B) representative meastatic nodules on the surface of the skin of nude mmice indicated by arrows).
Supplementary Figure 4 from Overexpression of Sirt7 Exhibits Oncogenic Property and Serves As a Prognostic Factor in Colorectal Cancer

Hongyan Yu,Wen Ye,Jiangxue Wu,Xiangqi Meng,Ran-yi Liu,Xiaofang Ying,Yi Zhou,Hui Wang,Changchuan Pan,Wenlin Huang

DOI: https://doi.org/10.1158/1078-0432.22449443.v1

2023-01-01

Abstract:PDF file - 1464KB, Sirt7 mediates ERK1/2 activation and subsequent mitogenic effects.(A) real-time PCR analysis of Sirt7 in THC8307 cells after ectopic expression of different siRNA. (B) Sirt7 induced increase in growth was subsequently rescued with Sirt7 shRNA, mean SEM, n=3, p<0.001.). (C) Expression of the Sirt7 mutants fails to induce ERK1/2 in 293T cell.
Figure S5 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Mingfeng Xue,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Liu,Xiaobo Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419837.v1

2023-01-01

Abstract:Supplementary figure S5. DAC treatment did not increase the risk of osteosarcoma proliferation.
Supplementary Figures 1 - 13 from SIRT1 Limits the Function and Fate of Myeloid-Derived Suppressor Cells in Tumors by Orchestrating HIF-1α–Dependent Glycolysis

Guangwei Liu,Yujing Bi,Bo Shen,Hui Yang,Yan Zhang,Xiao Wang,Huanrong Liu,Yun Lu,Jiongbo Liao,Xi Chen,Yiwei Chu

DOI: https://doi.org/10.1158/0008-5472.22401441.v1

2023-01-01

Abstract:PDF file - 436K, Fig.S1. MDSC polarizing differentiation condition alters glycolytic activity. Fig.S2.MDSC SIRT1 expansions in spleen and tumor of SIRT1KO and WT-bearing tumor mice. Fig.S3.SIRT1 deficiency MDSCs showed normal cell death and proliferation. Fig.S4.SIRT1 is required for MDSC polarization. Fig.S5.Characterization of surface marker of bone marrow-derived MDSCs. Fig.S6.SIRT1 intrinsicly controls the function and differentiation of tumor MDSCs. Fig.S7.The potentiating killing activity of SIRT1-/- MDSCs is associated with the higher glycolytic activity. Fig.S8.CD115+ monocytic MDSC effects in tumor killing. Fig.S9.SIRT1 deficiency from MDSCs could not alter the activation of NF-κB signaling after LPS treatment. Fig.S10.SIRT1-dependent MDSC glycolytic activity changes are associated with mTOR-HIF1α pathway. Fig.S11.SIRT-HIF axis directs the function and fate of MDSC associated with glycolytic activity. Fig.S12.SIRT-HIF axis potentiates glycolytic activity and tumor killing ability. Fig.S13.SIRT1 masters MDSC function and fate in tumor through mTOR/HIF1α dependent glycolytic pathway.
Supplementary Figure 5 from Overexpression of Sirt7 Exhibits Oncogenic Property and Serves as a Prognostic Factor in Colorectal Cancer

Hongyan Yu,Wen Ye,Jiangxue Wu,Xiangqi Meng,Ran-yi Liu,Xiaofang Ying,Yi Zhou,Hui Wang,Changchuan Pan,Wenlin Huang

DOI: https://doi.org/10.1158/1078-0432.22449440

2023-01-01

Abstract:PDF file - 2515KB, Sirt7 induces CRC cell migration in vitro partly dependent on the ERK activated. PD98059 can inhibit the migration of THC8307 that overexpressed Sirt7 while the inhibited effect was not depentent on the dose of PD98059.
Supplementary Figure 2 from Overexpression of Sirt7 Exhibits Oncogenic Property and Serves as a Prognostic Factor in Colorectal Cancer

Hongyan Yu,Wen Ye,Jiangxue Wu,Xiangqi Meng,Ran-yi Liu,Xiaofang Ying,Yi Zhou,Hui Wang,Changchuan Pan,Wenlin Huang

DOI: https://doi.org/10.1158/1078-0432.22449449

2023-01-01

Abstract:PDF file - 1787KB, Ectopic overexpression of Sirt7 enhances colorectal carcinoma cells migration in vitro. Representative results of transwell assays demonstrate that down-regulation Sirt7 expression levels in SW620 inhibited the cells migration compared the NC group. Columns - mean of triplicate experiments. *, p<0.05, independent student's test.
Supplementary Figure 2 from SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma Via BCL2-Associated X Protein–Dependent Apoptotic Pathway

Long-Kuan Ran,Yong Chen,Zhenzhen Zhang,Na-Na Tao,Ji-Hua Ren,Zhou Li,Hua Tang,Xiang Chen,Ke Chen,Wanyu Li,Aiping Huang,Juan Chen

DOI: https://doi.org/10.1158/1078-0432.22455327.v1

2023-01-01

Abstract:SIRT6 depletion increased cell sensitivity to doxorubicin. Cells in different groups with or without doxorubicin treatment were subjected to flow cytometry with Annexin V/PI (A) and to PARP cleavage analysis (B). *, p<0.01.
Supplementary Figure 1 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Sharad Sharma,Junying Zeng,Chun-Mei Zhuang,Yong-Qing Zhou,Hang‐Ping Yao,Xing Hu,Ruiwen Zhang,Ming‐Hai Wang

DOI: https://doi.org/10.1158/1535-7163.22497787

2023-01-01

Abstract:PDF file - 63K, Figure S1: Expression of RON and MET by breast cancer MCF-7, T-47D and ZR-75-1 cells.
Supplementary Figure Legends from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

Tingyu Wu,Wei Chen,Yongwang Zhong,Xiaodan Hou,Shengyun Fang,Chen-Ying Liu,Guanghui Wang,Tong Yu,Yu-Yang Huang,Xuesong Ouyang,Henry Q.X. Li,Long Cui,Yili Yang

DOI: https://doi.org/10.1158/1535-7163.22507968.v1

2023-01-01

Abstract:Bortezomib and KPT330 co-treatment inhibit patients-derived xenografts in nude mice.
Supplement Figure 6 from Targeting an Inducible SALL4-Mediated Cancer Vulnerability with Sequential Therapy

Junyu Yang,Chong Gao,Miao Liu,Yao-Chung Liu,Junsu Kwon,Jun Qi,Xi Tian,Alicia Stein,Yanjing V. Liu,Nikki R. Kong,Yue Wu,Shenyi Yin,Jianzhong Xi,Zhiyuan Chen,Kalpana Kumari,Hannan Wong,Hongbo Luo,Leslie E. Silberstein,Julie A.I. Thoms,Ashwin Unnikrishnan,John E. Pimanda,Daniel G. Tenen,Li Chai

DOI: https://doi.org/10.1158/0008-5472.22430473.v1

2023-01-01

Abstract:Supplement Figure 6
Supplement Figure 5 from Targeting an Inducible SALL4-Mediated Cancer Vulnerability with Sequential Therapy

Junyu Yang,Chong Gao,Miao Liu,Yao-Chung Liu,Junsu Kwon,Jun Qi,Xi Tian,Alicia Stein,Yanjing V. Liu,Nikki R. Kong,Yue Wu,Shenyi Yin,Jianzhong Xi,Zhiyuan Chen,Kalpana Kumari,Hannan Wong,Hongbo Luo,Leslie E. Silberstein,Julie A.I. Thoms,Ashwin Unnikrishnan,John E. Pimanda,Daniel G. Tenen,Li Chai

DOI: https://doi.org/10.1158/0008-5472.22430476

2023-01-01

Abstract:Supplement Figure 5
Expression analysis and biological regulation of silencing regulatory protein 6 (SIRT6) in cutaneous squamous cell carcinoma

Sai Chen,Hongxia Chen,Xu Wang,Dongmei Zhang,Li Zhang,Jiawei Cheng,Qi Zhang,Zhixiang Hua,Xu Miao,Jian Shi

DOI: https://doi.org/10.1016/j.abd.2023.08.010

Abstract:Background: Cutaneous squamous cell carcinoma (CSCC) is one of the most common types of skin cancer worldwide. Therefore, the identification of biomarkers associated with CSCC progression could aid in the early detection of high-risk squamous cell carcinoma and the development of novel therapeutic strategies. Objective: This study aimed to investigate the expression patterns of silent mating type Information Regulation 2 homolog 6 (SIRT6) in CSCC and its clinical significance. Methods: The protein expression level of SIRT6 in tissues was detected by immunohistochemistry, and the correlation between SIRT6 expression and clinicopathological parameters in CSCC patients was analyzed. The relative expression of SIRT6 in CSCC cell lineage and tissue specimens was determined by western blotting and PCR. The effect of SIRT6 silencing on cell proliferation was evaluated using cell counting kit 8. Wound healing, transwell method, and flow cytometry were used to investigate the migration, invasion, and cell cycle distribution/apoptosis of CSCC cells after SIRT6 silencing, respectively. Western blot was used to detect the expression of EMT (Epithelial-Mesenchymal Transition), cycle, apoptosis, and other related proteins. Results: The high expression of SIRT6 was correlated with the location of cancer tissue and Broder staging in CSCC patients. Knockdown of SIRT6 inhibited the proliferation, migration, invasion and EMT of CSCC cells, and promoted their apoptosis, with cells blocked in G1 phase. Study limitations: No animal experiments were conducted to further verify the results. Conclusion: Decreased expression of SIRT6 can inhibit the occurrence and development of CSCC.
Supplementary Figure 1 from Overexpression of Sirt7 Exhibits Oncogenic Property and Serves as a Prognostic Factor in Colorectal Cancer

Hongyan Yu,Wen Ye,Jiangxue Wu,Xiangqi Meng,Ran-yi Liu,Xiaofang Ying,Yi Zhou,Hui Wang,Changchuan Pan,Wenlin Huang

DOI: https://doi.org/10.1158/1078-0432.22449452

2023-01-01

Abstract:PDF file - 285KB, The expression of Sirt7 protein in colorectal cancer sections. Representative immunohistochemical images of colorectal cancer tissue specimens indicating negative or weakly detectable Sirt7 staining (A and B), moderate Sirt7 staining (C), and strong Sirt7 staining (D) are shown. Magnification is x 200 (A, B, C and D).
Supplemental Figure 1 from ADA-07 Suppresses Solar Ultraviolet–Induced Skin Carcinogenesis by Directly Inhibiting TOPK

Ge Gao,Tianshun Zhang,Qiushi Wang,Kanamata Reddy,Hanyong Chen,Ke Yao,Keke Wang,Eunmiri Roh,Tatyana Zykova,Weiya Ma,Joohyun Ryu,Clara Curiel-Lewandrowski,David Alberts,Sally E. Dickinson,Ann M. Bode,Ying Xing,Zigang Dong

DOI: https://doi.org/10.1158/1535-7163.22507695.v1

2023-01-01

Abstract:ADA-07 synthesis, MS analysis and cytotoxicity assays.

Supplemental Methods and Figure S1 from SIRT6 Promotes COX-2 Expression and Acts as an Oncogene in Skin Cancer

Data from SIRT6 Promotes COX-2 Expression and Acts as an Oncogene in Skin Cancer

Tumor and Stem Cell Biology SIRT 6 Promotes COX-2 Expression and Acts as an Oncogene in Skin Cancer

Supplemental Figures 1-5 from SIRT2 Deacetylates and Inhibits the Peroxidase Activity of Peroxiredoxin-1 to Sensitize Breast Cancer Cells to Oxidant Stress-Inducing Agents

Supplementary Figure 3 from Overexpression of Sirt7 Exhibits Oncogenic Property and Serves as a Prognostic Factor in Colorectal Cancer

Supplementary Figure 4 from Overexpression of Sirt7 Exhibits Oncogenic Property and Serves As a Prognostic Factor in Colorectal Cancer

Figure S5 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Supplementary Figures 1 - 13 from SIRT1 Limits the Function and Fate of Myeloid-Derived Suppressor Cells in Tumors by Orchestrating HIF-1<b>α</b>–Dependent Glycolysis

Supplementary Figure 5 from Overexpression of Sirt7 Exhibits Oncogenic Property and Serves as a Prognostic Factor in Colorectal Cancer

Supplementary Figure 2 from Overexpression of Sirt7 Exhibits Oncogenic Property and Serves as a Prognostic Factor in Colorectal Cancer

Supplementary Figure 2 from SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma Via BCL2-Associated X Protein–Dependent Apoptotic Pathway

Supplementary Figure 1 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Supplementary Figure Legends from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

Supplement Figure 6 from Targeting an Inducible SALL4-Mediated Cancer Vulnerability with Sequential Therapy

Supplement Figure 5 from Targeting an Inducible SALL4-Mediated Cancer Vulnerability with Sequential Therapy

Expression analysis and biological regulation of silencing regulatory protein 6 (SIRT6) in cutaneous squamous cell carcinoma

Supplementary Figure 1 from Overexpression of Sirt7 Exhibits Oncogenic Property and Serves as a Prognostic Factor in Colorectal Cancer

Supplemental Figure 1 from ADA-07 Suppresses Solar Ultraviolet–Induced Skin Carcinogenesis by Directly Inhibiting TOPK